Need to control blood sugar? There's a drink for that, says UBC prof

January 07, 2020

With more people with diabetes and pre-diabetes looking for strategies to help control blood sugar, new research from UBC's Okanagan campus suggests that ketone monoester drinks--a popular new food supplement--may help do exactly that.

"There has been a lot of excitement and interest in ketone drinks and supplements, which have really only been on the market and available to consumers for the last couple of years," says Jonathan Little, associate professor at UBC Okanagan's School of Health and Exercise Sciences and study lead author. "Because they're so new, there's very little research on how they can influence metabolism and we're among the first to look at their use in non-athletes."

Little says that Type 2 diabetes is a disease whereby the body is unable to control the level of sugar in the blood because defects in the functioning of a hormone called insulin.

"It's a disease that's becoming alarmingly common in Canada and approaching what many would consider epidemic levels," he says. "While Type 2 diabetes can be controlled with medications or injectable insulin, many people are looking to options that don't require taking pills every day or that are less invasive."

Ketone supplements are proving fertile ground for research into Type 2 diabetes because, according to Little, ketones are the natural fuel source of the body when it's in ketosis--the metabolic byproduct of consuming a low carbohydrate, ketogenic diet.

"There is mounting evidence that a low carbohydrate ketogenic diet is very effective in controlling blood sugar and even reversing Type 2 diabetes," says Little. "We wanted to know what would happen if artificial ketones were given to those with obesity and at risk for Type 2 diabetes but who haven't been dieting."

To test the idea, Little and his team asked 15 people to consume a ketone drink after fasting overnight. After 30 minutes, they were then asked to drink a fluid containing 75 grams of sugar while blood samples were taken.

"It turns out that the ketone drink seemed to launch participants into a sort of pseudo-ketogenic state where they were better able to control their blood sugar levels with no changes to their insulin," explains Little. "It demonstrates that these supplements may have real potential as a valuable tool for those with Type 2 diabetes."

Little is quick to point out that ketone supplements are not a magic bullet in managing the disease.

"There are a number of problems that we still have to work out, including the fact that we still don't know what the long-term effects of consuming ketones are," he says. "And not to mention that the drink itself tastes absolutely terrible."

"But for those that aren't able to follow a strict and challenging ketogenic diet or for those that are looking for a new way to control blood sugars, this may be another strategy in helping to manage Type 2 diabetes."
-end-
The study was published in the American Journal of Clinical Nutrition with funding from the Heart and Stroke Foundation of Canada.

University of British Columbia Okanagan campus

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.